Clinical Trials
15 trialsNCT01727388 2025-09-19
RIFIONA
Centre Hospitalier Universitaire, Amiens
Phase 3 Completed
NCT03499808 2025-09-09
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
SWOG Cancer Research Network
Phase 2 Completed
NCT06848400 2025-07-09
Capsule Gastric Endoscopy for Gastric Disease Screening in Simulated Home Scenarios
Nanfang Hospital, Southern Medical University
Phase NA Recruiting
NCT03824366 2025-01-10
MAP-RT
Washington University School of Medicine
Phase NA Completed
NCT05726097 2024-02-28
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
Region Skane
Phase 3 Completed
NCT00114985 2023-05-03
Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding
Dana-Farber Cancer Institute
Phase 2 Completed
NCT03855904 2022-10-04
HemosprayTM for Gastrointestinal Bleeding From Cancer
King Chulalongkorn Memorial Hospital
Phase NA Unknown
NCT02820077 2020-08-31
Hemostatic Powder Versus Clinical Management for the Treatment of Upper Gastrointestinal Bleeding From Tumor Lesions
Instituto do Cancer do Estado de São Paulo
Phase NA Terminated
NCT02965209 2018-02-14
ENMSET
Evangelisches Krankenhaus Düsseldorf
Phase NA Completed
NCT01169220 2017-10-05
Bowel Preparation for Inpatient Colonoscopy
Santa Clara Valley Health & Hospital System
Phase 4 Completed
NCT01623206 2017-08-24
Desmopressin (DDAVP) in Patients With Colorectal Cancer and Rectal Bleeding
Laboratorio Elea Phoenix S.A.
Phase 2 Completed
NCT02732483 2016-04-08
Role of Hemostatic Powder (Endo-clotTM) in Success and Prevention of Bleeding Within Gastric Cancer Patients With Bleeding
Yonsei University
Phase 2 Unknown
NCT01103492 2015-01-05
Treatment of Hemorrhagic Radiation Proctitis Using the Halo System
University Hospitals Cleveland Medical Center
Phase NA Completed
NCT00844675 2012-10-18
Effects of Oral Rabeprazole on the Prevention of Ulcer Bleeding Following Endoscopic Mucosal Resection
The Catholic University of Korea
Phase 4 Completed
NCT01549418 2012-03-09
ASAPOL
Maria Sklodowska-Curie National Research Institute of Oncology
Phase 4 Unknown